{"nct_id":"NCT06788912","title":"Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-03-20","start_date_type":"ACTUAL","primary_completion_date":"2032-02-06","primary_completion_date_type":"ESTIMATED","completion_date":"2032-02-06","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}